Follow on Telegram

science/health

AI and Multi-Omics: A New Frontier in Precision Drug Discovery

The Convergence of AI and Multi-Omics Precision medicine aims to tailor treatments to individual patients, and two powerful technologies are now being combined to make this goal more achievable: multi-omics and artificial intelligence. Multi-omics refers to the integrated analysis of different biological data layers—including genomics, proteomics, metabolomics, and transcriptomics.

GLP-1 Drugs Like Semaglutide Show Promise in Reducing Addiction and Overdose Risk

A landmark study published in Nature Medicine has revealed that semaglutide and other GLP-1 receptor agonists—best known for treating diabetes and obesity—may have unexpected benefits in combating addiction. Researchers analyzed health records from more than 600,000 U.S. veterans and found that patients taking GLP-1 drugs showed

New Diabetes Pill Targets Muscle Metabolism Instead of Hunger

A new experimental pill for diabetes and obesity works through a fundamentally different mechanism than existing drugs like Ozempic, according to research published in Science Daily. How It Works Instead of targeting hunger signals in the brain, the experimental treatment activates metabolism directly in skeletal muscle. This approach helps: * Lower

Long-Term Study Links French Fry Consumption to Increased Diabetes Risk

A large-scale study tracking more than 205,000 participants across nearly four decades has found a notable association between french fry consumption and type 2 diabetes risk. Researchers discovered that eating three servings of fries per week was linked to a 20% higher risk of developing the condition compared to

Brain Scans Reveal Two Distinct Subtypes of Autism Based on Brain Connectivity Patterns

Two Autism Subtypes Identified Through Brain Connectivity Analysis A recent study has provided compelling evidence that autism may not be a single condition but rather includes at least two biologically distinct subtypes, each defined by different patterns of brain communication. The Research Approach Scientists combined brain imaging data from nearly

Microsoft Launches Discovery Platform for Scientific R&D with Ginkgo Bioworks Partnership

Microsoft has announced the launch of its Discovery platform, a new initiative aimed at supporting scientific research and development efforts. The platform has been introduced in partnership with Ginkgo Bioworks, a company specializing in synthetic biology and cell programming. The collaboration seeks to leverage Microsoft's technological infrastructure with

Researchers Identify Protein That May Limit CAR T-Cell Therapy Effectiveness

CAR T-cell therapy reprograms a patient's own immune cells to recognize and attack cancer cells. While the treatment has shown success against certain blood cancers, the engineered cells often become less effective as they develop an "exhausted" state. Researchers have identified a protein called NFIL3 as